Assessment of extra-parenchymal lung involvement in asymptomatic cancer patients with COVID-19 pneumonia detected on 18F-FDG PET-CT studies

Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):768-776. doi: 10.1007/s00259-020-05019-y. Epub 2020 Sep 8.

Abstract

Background: Lung involvement in patients with coronavirus disease 2019 (COVID-19) undergoing PET-CT has been previously reported. However, FDG uptake outside lung parenchyma was poorly characterized in detail. We evaluated the extra-parenchymal lung involvement in asymptomatic cancer patients with COVID-19 pneumonia through 18F-FDG PET-CT.

Methods: A total of 1079 oncologic 18F-FDG PET-CT were performed between February 2 and May 18, 2020. Confirmed COVID-19 pneumonia was defined as characteristic ground-glass bilateral CT infiltrates and positive genetic/serologic tests. Nonmetastatic extra-parenchymal lung PET-CT findings were evaluated through qualitative (visual), quantitative (measurements on CT), and semiquantitative (maximum standardized uptake value: SUVmax on PET) interpretation. Clinical data, blood tests, and PET-CT results were compared between patients with and without COVID-19 pneumonia.

Results: A total of 23 18F-FDG PET-CT scans with pulmonary infiltrates suggestive of COVID-19 and available laboratory data were included: 14 positive (cases) and 9 negative (controls) for COVID-19 infection, representing a low prevalence of COVID-19 pneumonia (1.3%). Serum lactate dehydrogenase and D-dimers tended to be increased in COVID-19 cases. Extra-parenchymal lung findings were found in 42.9% of patients with COVID-19, most frequently as mediastinal and hilar nodes with 18F-FDG uptake (35.7%), followed by incidental pulmonary embolism in two patients (14.3%). In the control group, extra-pulmonary findings were observed in a single patient (11.1%) with 18F-FDG uptake located to mediastinal, hilar, and cervical nodes. Nasopharyngeal and hepatic SUVmax were similar in both groups.

Conclusion: In cancer patients with asymptomatic COVID-19 pneumonia, 18F-FDG PET-CT findings are more frequently limited to thoracic structures, suggesting that an early and silent distant involvement is very rare. Pulmonary embolism is a frequent and potentially severe finding raising special concern. PET-CT can provide new pathogenic insights about this novel disease.

Keywords: 18F-FDG; COVID-19; Cancer; Extra-parenchymal lung; PET-CT; SARS-CoV-2.

MeSH terms

  • COVID-19 / complications
  • COVID-19 / diagnostic imaging*
  • COVID-19 / epidemiology
  • COVID-19 Testing
  • Common Bile Duct Neoplasms
  • Female
  • Fluorodeoxyglucose F18 / administration & dosage*
  • Humans
  • Lung / diagnostic imaging*
  • Male
  • Neoplasms / diagnostic imaging*
  • Pneumonia / complications
  • Pneumonia / diagnostic imaging
  • Positron Emission Tomography Computed Tomography / methods*
  • Radiopharmaceuticals / administration & dosage*
  • SARS-CoV-2

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18